Chronic Myelomonocytic Leukemia Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
P
Recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Orlando, Florida
  • +3 more
2022-03-31
Mar 31, 2022
S
Recruiting
  • Acute Myeloid Leukemia
  • +14 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
2022-04-07
Apr 7, 2022
M
Recruiting
  • Acute Bilineal Leukemia
  • +8 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-04-05
Apr 5, 2022
T
Recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Hematopoietic Cell Transplantation
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
2022-04-01
Apr 1, 2022
F
Recruiting
  • Juvenile Myelomonocytic Leukemia
  • +27 more
  • CD8+ and CD4+ Donor Memory T-cells-expressing HA1-Specific TCR
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-16
Mar 16, 2022
K
Active, not recruiting
  • Myelodysplastic Syndromes
  • +2 more
  • Newcastle, New South Wales, Australia
  • +10 more
2022-03-29
Mar 29, 2022
J
Recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Birmingham, Alabama
  • +24 more
2022-03-24
Mar 24, 2022
H
Recruiting
  • Leukemia, Myeloid, Acute
  • +5 more
  • Duesseldorf, NRW, Germany
  • +10 more
2022-03-21
Mar 21, 2022
P
Completed
  • Myelodysplastic Syndrome
  • +2 more
  • Birmingham, Alabama
  • +32 more
2022-03-14
Mar 14, 2022
R
Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +36 more
  • Buffalo, New York
    Roswell Park Cancer Institute
2022-03-17
Mar 17, 2022
D
Active, not recruiting
  • Myelodysplastic Syndrome
  • +2 more
  • GVAX
  • +6 more
  • Boston, Massachusetts
  • +3 more
2022-02-23
Feb 23, 2022
F
Recruiting
  • Acute Leukemia
  • +18 more
  • Allogeneic Hematopoietic Stem Cell Transplantation
  • +8 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-16
Mar 16, 2022
M
Active, not recruiting
  • Acute Myeloid Leukemia
  • +6 more
  • Baltimore, Maryland
  • +2 more
2022-02-25
Feb 25, 2022
F
Not yet recruiting
  • Acute Myeloid Leukemia
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-03-07
Mar 7, 2022
M
Recruiting
  • Chronic Myelomonocytic Leukemia
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-04
Mar 4, 2022
N
Active, not recruiting
  • Anemia
  • +3 more
  • Epoetin Alfa
  • +2 more
  • Birmingham, Alabama
  • +512 more
2022-03-01
Mar 1, 2022
M
Recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +25 more
  • Allogeneic Natural Killer Cell Line NK-92
  • +10 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-03-01
Mar 1, 2022
C
Active, not recruiting
  • Accelerated Phase Chronic Myelogenous Leukemia
  • +125 more
  • tetanus-CMV fusion peptide vaccine
  • laboratory biomarker analysis
  • Duarte, California
    City of Hope Medical Center
2022-02-28
Feb 28, 2022
F
Recruiting
  • Acute Lymphoblastic Leukemia
  • +11 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
2022-02-25
Feb 25, 2022
M
Active, not recruiting
  • Acute Myeloid Leukemia With Multilineage Dysplasia
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-25
Feb 25, 2022
C
Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +6 more
  • Duarte, California
    City of Hope Medical Center
2022-02-17
Feb 17, 2022
M
Active, not recruiting
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
2022-02-14
Feb 14, 2022